Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Povidone prices in Germany, the highest-cost reporting region, corrected 5.0% in Q2 2026, slipping from USD 8.20/KG in Q1 to USD 7.79/KG as N-vinylpyrrolidone monomer cost softening and post-spring pharmaceutical tablet formulation and cosmetic procurement moderation reversed the sustained Q3 2025 through Q1 2026 firming trend. Globally, the average eased from USD 5.737/KG in Q1 to USD 5.450/KG in Q2, a 5.0% decline. For H2 2026, a global average of USD 5.30-5.90/KG is expected, with stabilisation as monomer costs normalise and steady pharmaceutical formulation, personal care, and industrial processing sector demand supports the market across all major regions.
Povidone, or polyvinylpyrrolidone, is a water-soluble synthetic polymer produced by free-radical polymerisation of N-vinylpyrrolidone monomer, itself synthesised from acetylene and butyrolactam via the Reppe process, yielding a range of molecular weight grades characterised by Fikentscher K-values from K-12 to K-90 that determine viscosity and binding properties for different end-use applications. The pharmaceutical formulation sector takes the largest pull, using K-30 and K-90 grades as tablet binders and granulation aids, K-12 as a disintegrant, and higher grades as film-forming solubilisers for poorly water-soluble active pharmaceutical ingredients in solid and liquid dosage forms. Complexation with iodine to form povidone-iodine antiseptic solutions and surgical scrub preparations adds significant hospital and consumer disinfection demand. Personal care applications as a hair fixative in styling gels and skin-feel enhancer in cosmetic formulations add further demand. Industrial use as a clarifying agent in wine and beer production and as a dispersant in adhesive and coating systems adds a supplementary segment. N-vinylpyrrolidone monomer costs, pharmaceutical procurement cycles, and regional polymer production capacity all feed into the price.
The balance of supply and demand for povidone through H2 2026 leans toward stabilisation following the Q2 correction. N-vinylpyrrolidone monomer costs are normalising after the Q1 2026 peak. Pharmaceutical tablet formulation procurement, povidone-iodine antiseptic restocking, and personal care sector demand provide consistent procurement support.
The main upside risk is a renewed NVP monomer cost spike from acetylene or butyrolactam feedstock supply disruption. The main downside risk is continued Chinese polymer surplus maintaining competitive pricing pressure below the forecast midpoint.
| Region | Price Forecast (USD/KG) | Key Driver |
| Global Average | 5.30 - 5.90 | NVP monomer normalisation and pharma/personal care demand |
| United States | 5.65 - 6.25 | Steady pharma tablet and antiseptic demand holds firm |
| China | 3.85 - 4.45 | Domestic polymer capacity keeps it the most affordable |
| Germany | 7.40 - 8.00 | High NVP and energy costs keep it the most expensive |
| India | 5.48 - 6.08 | Growing pharma and personal care demand holds a firm middle |
US Povidone prices averaged USD 6.31/KG in Q2 2026, down 5.0% from USD 6.64/KG in Q1 2026. N-vinylpyrrolidone monomer cost softening and post-spring pharmaceutical tablet and antiseptic procurement moderation eased the market from the Q1 2026 firming peak.
Why did the price of Povidone change in Q2 2026 in the United States?
N-vinylpyrrolidone monomer cost softening reduced the polymer production floor. Post-spring pharmaceutical tablet formulation and povidone-iodine antiseptic procurement moderation reduced buying urgency. Personal care demand normalised near USD 6.31/KG after the Q1 peak.
Chinese Povidone prices averaged USD 4.29/KG in Q2 2026, down 5.1% from USD 4.52/KG in Q1 2026, the lowest among the tracked markets. Soft domestic NVP monomer costs and post-spring procurement moderation eased the market from the Q1 2026 peak.
Why did the price of Povidone change in Q2 2026 in China?
Soft domestic NVP monomer costs reduced the polymer production floor. Post-spring pharmaceutical export and personal care procurement moderation reduced buying urgency. Domestic polymer capacity maintained China as the most affordable source near USD 4.29/KG.
German Povidone prices averaged USD 7.79/KG in Q2 2026, down 5.0% from USD 8.20/KG in Q1 2026, the highest among the tracked markets. Softening NVP monomer and energy costs and post-spring pharmaceutical and cosmetic procurement moderation eased the European market from the Q1 firming peak.
Why did the price of Povidone change in Q2 2026 in Germany?
Softening N-vinylpyrrolidone monomer and energy costs eased the European polymer production floor. Post-spring pharmaceutical tablet formulation and personal care procurement moderation reduced buying urgency. The market corrected to USD 7.79/KG from the Q1 2026 firming peak.
Indian Povidone prices averaged USD 6.02/KG in Q2 2026, down 5.0% from USD 6.34/KG in Q1 2026. Soft NVP monomer import costs and post-spring pharmaceutical and personal care procurement moderation eased the market from the Q1 peak.
Why did the price of Povidone change in Q2 2026 in India?
Soft NVP monomer import costs reduced the production floor. Post-spring pharmaceutical tablet and personal care procurement moderation eased buying urgency. Export and domestic price normalisation held the market near USD 6.02/KG after the Q1 firming peak.
US Povidone prices averaged USD 6.64/KG in Q1 2026, up 4.1% from Q4 2025. Firmer NVP monomer costs and winter pharmaceutical tablet formulation and antiseptic procurement held the market at the Q1 peak.
Why did the price of Povidone change in Q1 2026 in the United States?
Firmer NVP monomer costs raised the polymer production floor. Winter pharmaceutical tablet granulation and povidone-iodine antiseptic procurement maintained buying at elevated levels. The market held at USD 6.64/KG before the Q2 2026 monomer softening and correction.
Chinese prices averaged USD 4.52/KG in Q1 2026, up 3.9% from Q4 2025. Firmer domestic NVP costs and post-Lunar New Year pharmaceutical export procurement held the market at the Q1 peak.
Why did the price of Povidone change in Q1 2026 in China?
Firmer domestic NVP monomer costs raised the production floor. Post-Lunar New Year pharmaceutical export and domestic procurement maintained buying at elevated levels. The market reached USD 4.52/KG before the Q2 NVP softening correction.
German prices averaged USD 8.20/KG in Q1 2026, up 4.1% from Q4 2025. Firmer NVP monomer and energy costs and strong pharmaceutical and cosmetic procurement held the European market at the quarterly peak.
Why did the price of Povidone change in Q1 2026 in Germany?
Firmer NVP monomer and energy costs raised the European production floor. Pharmaceutical tablet and cosmetic formulation procurement maintained elevated buying. The market held at USD 8.20/KG before the Q2 softening.
Indian prices averaged USD 6.34/KG in Q1 2026, up 3.9% from Q4 2025. Firmer NVP import costs and pharmaceutical and personal care procurement held the market at the Q1 firming peak.
Why did the price of Povidone change in Q1 2026 in India?
Firmer NVP monomer import costs raised the production floor. Pharmaceutical tablet and personal care procurement maintained buying. The market held at USD 6.34/KG before the Q2 monomer cost correction.
Global Povidone prices rose steadily through Q3 and Q4 2025 and into Q1 2026 on firming NVP monomer costs and consistent pharmaceutical and personal care demand, before correcting in Q2 2026 as monomer costs softened. The average climbed from USD 5.20/KG in Q2 2025 to USD 5.304/KG in Q3, USD 5.516/KG in Q4, and USD 5.737/KG in Q1 2026, then corrected to USD 5.450/KG in Q2 2026, a net gain of about 4.8% over the window. NVP monomer cost cycles and pharmaceutical and personal care procurement drove the rising trajectory before the Q2 correction.
| Quarter | Price (USD/KG) | QoQ Change | Direction |
| Q2 2026 | 5.450 | -5.0% | ↓ Falling |
| Q1 2026 | 5.737 | +4.0% | ↑ Rising |
| Q4 2025 | 5.516 | +4.0% | ↑ Rising |
| Q3 2025 | 5.304 | +2.0% | ↑ Rising |
| Q2 2025 | 5.20 | - | - Stable |
| Q3 2026 | In Progress | - | - In Progress |
Povidone prices firmed steadily through 2025 on rising NVP monomer costs and consistent pharmaceutical and personal care demand. The global average opened near USD 5.10/KG in Q1 2025 and closed at USD 5.516/KG in Q4, a full-year gain of about 8.2%. NVP monomer cost firming and growing pharmaceutical tablet granulation and antiseptic demand drove the consistent upward trajectory throughout the year.
US prices firmed from about USD 6.00/KG in Q1 2025 to USD 6.38/KG by Q4, a gain of 6.3%. Consistent pharmaceutical tablet formulation and povidone-iodine antiseptic demand supported the upward trend.
Chinese prices firmed from roughly USD 4.10/KG in Q1 2025 to USD 4.35/KG by Q4, a gain of 6.1%. Growing pharmaceutical export and domestic personal care demand drove the firming despite domestic polymer capacity.
German prices firmed from about USD 7.40/KG in Q1 2025 to USD 7.88/KG by Q4, a gain of 6.5%. Consistent pharmaceutical formulation and cosmetic demand and firm NVP and energy costs supported the market.
Indian prices firmed from roughly USD 5.75/KG in Q1 2025 to USD 6.10/KG by Q4, a gain of 6.1%. Growing pharmaceutical tablet and personal care demand drove consistent firming through the year.
Expert Market Research: Your Source for Real-Time Povidone Price Intelligence
Expert Market Research tracks Povidone prices continuously across every major producing and consuming region. The team traces causation through N-vinylpyrrolidone monomer economics, pharmaceutical formulation and antiseptic procurement cycles, and regional polymer production capacity. Contact Expert Market Research today for Povidone pricing data, bespoke market analysis, and strategic procurement advisory.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Pharmaceutical tablet binder and granulation aid in K-30 and K-90 grades, with K-12 as disintegrant and higher grades as film formers and solubilisers for poorly water-soluble APIs, takes the largest share. Povidone-iodine antiseptic formulations for wound care and surgical disinfection, personal care use as hair fixative in styling gels, and industrial use as a clarifying agent in beverages also consume significant volumes globally.
The Q2 2026 average was USD 6.31/KG in the United States, USD 4.29/KG in China, USD 7.79/KG in Germany, and USD 6.02/KG in India. Germany remains the highest-priced market after the Q2 correction.
The global average rose to a peak of USD 5.737/KG in Q1 2026 before correcting to USD 5.450/KG in Q2, a 5.0% quarterly decline. NVP monomer cost firming through Q1 and post-spring procurement moderation in Q2 drove the rise-and-correct pattern.
N-vinylpyrrolidone monomer cost softening reduced the polymer production floor. Post-spring pharmaceutical tablet formulation and personal care procurement moderation reduced buying urgency from the Q1 seasonal firming peak, allowing the correction.
The global average is expected in the USD 5.30 to 5.90/KG range for H2 2026, with stabilisation as NVP monomer costs normalise and pharmaceutical formulation, antiseptic, and personal care sector demand resumes at steady levels.
Germany sits highest on NVP monomer and energy import costs, the United States and India hold a firm middle on pharmaceutical and personal care demand, and China prices lowest on domestic polymer production capacity.
This report is updated monthly. For real-time pricing intelligence, contact the Expert Market Research team directly.
Prices respond mainly to NVP monomer costs derived from acetylene and butyrolactam feedstock pricing, pharmaceutical formulation procurement cycles, and personal care sector spending. Acetylene and butyrolactam prices are key upstream cost signals.
Europe and North America host established povidone production capacity, with growing Asian producers. Any NVP monomer cost shift ripples across povidone markets within one quarter.
Buyers can use quarterly trends and forecasts to time pharmaceutical and personal care formulation contracts around NVP monomer cost cycles, build cover when monomer signals tighten, and monitor acetylene and butyrolactam prices as primary upstream cost signals.
One Year Subscription
One Year Subscription
USD 799
USD 699
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.